Radiopharm Theranostics Limited
Radiopharm Theranostics Limited (RADX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · RADX · as of Jun 9, 2026
Key Statistics
Explore Radiopharm Theranostics Limited Data
radx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 100.0%
The RADX analyst consensus is Buy, based on ratings from 1 Wall Street analysts over the past 3 months. The average 12-month price target is $10.50, representing +149.41% upside from the current price of $4.21.
Competitors & Peers
radx competitorsRADX
ADXN
BCLI
CDIO
CYCN
IBOStock Performance
Full HistoryAbout Radiopharm Theranostics Limited
Radiopharm Theranostics Limited an Australian company established in Carlton in 2021, specializes in the research and development of cutting-edge radiopharmaceutical treatments. Their mission is to a…
what is radiopharm theranostics limited · radx stock overview · radiopharm theranostics limited company profile · who is radiopharm theranostics limited ceo · radx NASDAQ · radiopharm theranostics limited headquarters · radiopharm theranostics limited business segments
About Stock Overview & Key Data
Radiopharm Theranostics Limited (RADX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Dec 5, 2024. As of the latest trading session, RADX stock price is $4.21, with a market capitalization of $5.4M. The stock has returned -13.02% over the past 12 months and -19.35% year-to-date.
According to 1 Wall Street analysts, the consensus rating for Radiopharm Theranostics Limited stock is Buy, with an average 12-month price target of $10.50. In fiscal year 2025, Radiopharm Theranostics Limited reported revenue of $3.6M and net income of -$38.3M. For detailed data — including Radiopharm Theranostics Limited revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Radiopharm Theranostics Limited (RADX) stock price is $4.21. The stock is traded on NASDAQ under the ticker symbol RADX. The 52-week range is $3.62 – $16.25.